Banco de dados - (CIANE)

Descrição deste banco de dados documental (Site da CIANE)
Atualmente 3109 fichas
➡ Canal do YouTube (tutorial)

https://ciane.net/id=1048

Criado em : 19 Nov 2004
Alterado em : 02 Dec 2007

➡ Modificar esta ficha
Siga este link somente se você tiver um palavra chave de editor!

Nota bibliográfica (sem autor) :

Preventing postpartum hemorrhage in low-resource settings. International Journal of Gynecology & Obstetrics 77 2002 267 275

Autores :

McCormick, M.L.; Sanghvi, H.C.G.; Kinzie, B.; McIntosh, N

Ano de publicação :

2002

URL(s) :

http://www.figo.org/content/PDF/AMDD_postpartum-he…

Résumé (français)  :

Abstract (English)  :

Objectives: To review the literature to determine the most effective methods for preventing postpartum hemorrhage PPH , the single most important cause of maternal death worldwide.

Methods: Systematic review of published randomized controlled trials and relevant reviews.

Results: Review of the literature confirms that active management of the third stage of labor, especially the administration of uterotonic drugs, reduces the risk of PPH due to uterine atony without increasing the incidence of retained placenta or other serious complications. Oxytocin is the preferred uterotonic drug compared with syntometrine, but misoprostol also can be used to prevent hemorrhage in situations where parenteral medications are not available e.g. at home births in developing countries.

Conclusions: The use of active management of the third stage of labor to prevent PPH due to uterine atony should be expanded, especially in developing country settings.

Sumário (português)  :

Resumen (español)  :

Comentários :

Argument (français) :

Une étude de la littérature montre que l’administration de médicaments utérotoniques réduit le risque d’hémoragies post-partum

Argument (English):

Review of the literature shows that the administration of uterotonic drugs reduces the risk of PPH

Argumento (português):

Argumento (español):

Palavras-chaves :

➡ hemorragia post-partum ; hormonas ; ocitocina (Syntocinon) ; misoprostol (Cytotec) ; indução

Autor da esta ficha :

Sandrine Péneau — 19 Nov 2004
➡ última atualização : Bernard Bel — 02 Dec 2007